Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipragliflozin with GLP-1 Receptor Agonists in T2DM
NCT02291874Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ipragliflozin in type 2 diabetes mellitus (T2DM), sponsored by Astellas Pharma. Started Oct 2014; status: completed.
02
Drugs
ipragliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02291874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291874.